VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: First quarter 2024 financial results
April 24, 2024 01:44 ET | Vistin Pharma ASA
Oslo, Norway, 24th of April 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2024. Revenue in the first quarter ended at MNOK 104 compared to...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Invitation to Q1 2024 conference call
April 16, 2024 07:00 ET | Vistin Pharma ASA
Oslo, Norway, 16 April 2024 Vistin Pharma ASA will release its first quarter results on Wednesday 24th of April 2024. Vistin Pharma will host a conference call for all shareholders and interested...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Mandatory notification of trade
March 22, 2024 16:59 ET | Vistin Pharma ASA
Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of NOK 22,10 per share. Espen W. Marcussen, Chair of the board in Pactum Vekst AS, is a primary insider and...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)
March 04, 2024 02:15 ET | Vistin Pharma ASA
Oslo, Norway, 4 March 2024 Vistin Pharma has aquired a 15% share in CF Pharma Kft. CF Pharma is an API CDMO located in Budapest, Hungary with a broad customer base of recognized international...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Key information relating to the proposed cash dividend
February 16, 2024 04:30 ET | Vistin Pharma ASA
The Board of Directors of Vistin Pharma ASA plans to propose to distribute a cash dividend of total NOK 1.00 per share, to be paid partly in June and November, for the accounting year of 2023. The...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results
February 16, 2024 01:45 ET | Vistin Pharma ASA
Oslo, Norway, 16th of February 2024 Vistin Pharma ASA (Vistin Pharma, OSE: VISTN) today announces the financial results for the fourth quarter of 2023. Vistin delivers another strong quarter with...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Invitation to Q4 2023 conference call
February 09, 2024 04:00 ET | Vistin Pharma ASA
Oslo, Norway, 9 February 2024 Vistin Pharma ASA will release its fourth quarter and preliminary 2023 results on Friday 16th of February 2024. Vistin Pharma will host a conference call for all...
VistinPharma_Primary_White-background.jpg
Ex dividend NOK 0.75 today
January 23, 2024 02:00 ET | Vistin Pharma ASA
The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024. ...
VistinPharma_Primary_White-background.jpg
Key information relating to the cash dividend to be paid by Vistin Pharma ASA
January 11, 2024 05:40 ET | Vistin Pharma ASA
Dividend amount (per share): NOK 0.75 Declared currency: NOK Last day including right: 22 January 2024 Ex-date: 23 January 2024 Record date: 24 January 2024 Payment date: 30 January...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Dividend of NOK 0.75 per share
January 11, 2024 05:35 ET | Vistin Pharma ASA
Oslo, Norway, 11 January 2024 Norwegian pharmaceutical company Vistin Pharma ASA (“Vistin Pharma”) announced today that the Board has decided for a dividend of NOK 0.75 per share. The dividend is...